A A Pract. 2026 Mar 12;20(3):e02165. doi: 10.1213/XAA.0000000000002165. eCollection 2026 Mar 1.
ABSTRACT
Urgent transcatheter edge-to-edge mitral valve repair (TEER) may offer a therapeutic alternative for patients with cardiogenic shock due to severe mitral regurgitation (MR). We reviewed 23 high-risk patients undergoing urgent TEER. Procedural success was 100%, with marked MR reduction and low periprocedural complication rates. Thirty-day and 1-year mortality were 17.4% and 30.4%, respectively. Among survivors with follow-up data, most demonstrated sustained symptomatic improvement. Percutaneous TEER may potentially serve as either definitive therapy or a temporizing intervention for patients in cardiogenic shock with prohibitive surgical risk while preserving the option for subsequent surgical mitral repair after improvement in clinical status.
PMID:41818469 | DOI:10.1213/XAA.0000000000002165